Since its introduction in 1968, flexible fibreoptic bronchoscopy has been widely employed in the evaluation and management of patients with pulmonary disorders (Khan et al., 1976) . The procedure is easily performed, is associated with few complications, and affords greater visualisation of the endobronchial tree than rigid bronchoscopy. Patienits can undergo this procedure with minimal discomfort, and biopsy of previously inaccessible areas of the lung may be accomplished using the standard biopsy forceps accompanying the flexible fibreoptic bronchoscope.
Recently, several studies have demonstrated a high degree of diagnostic accuracy employing fibreoptic bronchoscopy for determining the aetiology of both focal and diffuse pulmonary infiltrates (Levin et al., 1974; Zavala, 1975; Cunningham et al., 1977) . The safety and diagnostic yield of this procedure applied specifically to immunocompromised hosts with pulmonary lesions requires analysis. These patients are frequently at risk for lung biopsy procedures, particularly due to the presence of arterial hypoxaemia, abnormal clotting factors, and thrombocytopenia (Greenman et al., 1975; Hanson et al., 1976) . The purpose of this study was to determine whether fibreoptic bronchoscopy employing brush and forceps biopsy is a safe and accurate method for determining the aetiology of pulmonary infiltrates in the immunocompromised patient. Material Levin et al. (1974) and Ellis (1975) . Patients received nothing by mouth for at least six hours before the procedure. Premedications including codeine (30-60 mg) and atropine (0A4-0-6 mg) were given intramuscularly 30 minutes before the procedure. The patients' oropharynx and naris were anaesthetised with 4% lidocaine. In addition, viscous lidocaine was used to anaesthetise and lubricate the naris. The Olympus BF 5B2 fibreoptic bronchoscope was passed transnasally (Smiddy et al., 1971) . Under direct vision, the vocal cords were examined and further anaesthetised with 2% lidocaine through the bronchoscope's suction and biopsy channel. The trachea was then entered and biopsy performed. When indicated, to ensure comfort and to facilitate the procedure diazepam (Valium), 5-10 mg, was administered intravenously. Topical anaesthetic (1% lidocaine) was instilled into the airways with careful dose monitoring.
Supplemental oxygen was administered through a single-prong catheter attached to the naris (Petty et al., 1973) . For one patient requiring assisted ventilation 'the bronchoscope was passed directly into the trachea through an endotracheal tube using an adaptor that provides a tight seal to maintain adequate -tidal volume and ventilation (Amikam et al., 1972) . Patients with platelet counts less than 50000/mm3 received platelet transfusions (10 platelet packs in most cases) during and immediately after the procedure to obtain platelet counts greater than 100 000/mm3.
After complete examination of the tracheobronchial tree, including subsegmental bronchi, if no endotracheal lesions were seen, the bronchoscope was guided directly or by fluoroscopy into the segment containing the lesion for biopsy. Under fluoroscopic guidance, the standard biopsy forceps that accompanies the Olympus bronchoscope was passed peripherally in a closed position until mild resistance was met. The position of the forceps was carefully checked with fluoroscopy in both the lateral and anteroposterior projections. The proximity of the forceps to the visceral pleura was also noted. When satisfactory placement in the areas of involvement was achieved, the forceps was retracted 1 to 2 cm and opened, then advanced under fluoroscopic guidance into the lesion or within 1 to 2 cm of the visceral pleura in diffuse disease or until moderate resistance was encountered. The forceps was gently closed and slowly retracted while the bronchoscope was secured in the same position or slowly advanced to ensure accurate repositioning of the bronchial brush or forceps. The specimen was withdrawn R. A. Matthay, W. C. Farmer, and D. Odero through the bronchoscope's biopsy channel. Multiple biopsy specimens were taken from the same or different areas of involvement. Unilateral biopsies were done to prevent the possible occurrence of bilateral pneumothoraces. Bronchial brushings (Fennessey, 1966; Fry and ManaloEstrella, 1970; Repsher et al., 1972; Finley et al., 1974) A specific infection was diagnosed by fibreoptic bronchoscopy in 14 patients. Table 5 shows that bacterial infection was identified most commonly followed by fungal organisms. A patient (RM) with histiocytic medullary reticulosis died with an invasive pulmonary Aspergillus fumigatus infection in spite of amphotericin B therapy (Fig. 1) No specific diagnosis was obtained by fibreoptic bronchoscopy in four patients. Subsequently two of these patients died, and a necropsy revealed radiation pneumonitis in one. No necropsy was performed in the other patient. The pulmonary infiltrates cleared spontaneously in the third patient with Hodgkin's disease, and in the fourth case a diagnosis of pulmonary Nocardia infection was made on repeat fibreoptic bronchoscopy.
COMPLICATIONS
The morbidity of bronchoscopy with transbronchial forceps and brush biopsy was low. Pneumothorax requiring a chest tube occurred as a result of two procedures. Mild, transient haemoptysis with an increase in alveolar filling on the chest radiograph was noted in two other patients, and in neither instance was blood transfusion necessary. Both patients with bleeding had leukaemia and were thrombocytopenic with platelet counts of 2400/mm3 and 40 000/mm3 respectively. In one the partial thromboplastin time was abnormal; however, in both, the pro- to 16 months later. Three deaths occurred within one week of the procedure and eight other patients died two to 20 (average 10) weeks after bronchoscopy. Resolution of the pulmonary infiltrates with discharge from hospital occurred in 10 of 14 pulmonary infections (71%) ( Table 5) .
Discussion
This study confirms that fibreoptic bronchoscopy using brush and forceps biopsy can be performed in immunocompromised hosts with an excellent diagnostic yield and with acceptable safety even when abnormal clotting factors, thrombocytopenia, and arterial hypoxaemia are present. The immunocompromised host frequently presents special problems which may increase the risk of lung biopsy procedures (Greenman et al., 1975; Hanson et al., 1976; Cunningham et al., 1977) . Arterial hypoxaemia and thrombocytopenia represent significant risk factors encountered in immunocompromised patients undergoing fibreoptic bronchoscopy (Hanson et al., 1976) . Supplemental oxygen, found to be useful by others (Albertini et al., 1975; Zavala, 1975) to protect against severe hypoxaemia during bronchoscopy, appeared to protect hypoxaemic patients in this study. Platelet transfusions administered during and immediately after bronchoscopy in severely thrombocytopenic patients appeared to prevent severe pulmonary haemorrhage in our study. The low incidence of bleeding (8%) in this series may be related to the fact that only two of 19 patients had renal failure. It is well known that patients with renal failure have a tendency to develop bleeding (Kazatchkine et al., 1976) , and recently Cunningham et al. (1977) have emphasised that Liraemic patients in their series had a high incidence of pulmonary haemorrhage after transbronchial biopsy (45%).
In addition to thrombocytopenia, Greenman et al. (1975) (Levin et al., 1974; Ellis, 1975; Zavala, 1975; Hanson et al., 1976) have indicated that fluoroscopic guidance should be used for transbronchial lung biopsy procedures with the fib,Aeoptic bronchoscope. A blind transbronchial lung biopsy may result in perforation of the visceral pleura and an increased incidence of pneumothorax. In addition, the use of fluoroscopy assists in confirming the location of the biopsy instrument in focal lesions, increasing the chance of obtaining a diagnosis.
The high diagnostic yield obtained by us in this study of immunocompromised hosts is comparable to that achieved by others performing transbronchial lung biopsy in both immunocompromised and non immunocompromised patients (Andersen and Fontana, 1972; Levin et al., 1974; Ellis, 1975; Zavala, 1975; Hanson et al., 1976; Cunningham et al., 1977) . Cunningham et al. (1977) evaluated fibreoptic bronchoscopy specifically in immunosuppressed patients, obtaining a 740 0 diagnostic yield (23 of 31 procedures) with forceps transbronchial biopsy and a 28% yield (9 of 31 procedures) with bronchial brush biopsy. In the present study brush biopsy and transbronchial forceps biopsy evaluated individually provided similar diagnostic yields of 63 and 68% respectively. However, the diagnostic yield was increased to 84% by combining the two procedures. Therefore, we recommend that both brush and forceps biopsies be performed in immunocomprotnised hosts with pulmonary infiltrates who are undergoing fibreoptic bronchoscopy.
